London: Obese, or overweight patients with breast might benefit less from treatment with docetaxel, a common chemotherapy drug, than lean patients, warn researchers. It is…
London: Obese, or overweight patients with breast might benefit less from treatment with docetaxel, a common chemotherapy drug, than lean patients, warn researchers. It is…